source
- Osivax bags flu vaccine rights to pursue combination shot visionOsivax has licensed an influenza vaccine from GC Biopharma, positioning the biotech to build on early evidence that its midphase candidate complements traditional flu shots.Fierce Biotech · 10h ago↗ source
- CDMO hiring struggles as demand for specialized talent outpaces supplyContract development and manufacturing organizations are finding it harder to fill positions, according to a search expert who tracks life-science talent. The surge in outsourcing has created a gap…
- Bausch + Lomb moves dry-eye eye drop to Phase 3 despite missing primary endpoint in Phase 2